Clinical Trial Update: Ovarian Hyperstimulation Syndrome (OHSS) Prevention With Agonist

View source ↗

Summary

Trial evaluating GnRH agonist–based prevention of ovarian hyperstimulation syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Hyperstimulation Syndrome

Drugs mentioned

• GnRH agonist (gonadotropin-releasing hormone agonist)

Snippet

Sponsor: University Hospital Schleswig-Holstein | Conditions: Ovarian Hyperstimulation Syndrome | Status: COMPLETED